Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

JUL 30, 2015 - Washington Times

A Must Read - Share

Amgen hikes 2015 forecast after 2Q increase in profit, sales

TRENTON, N.J. (AP) - Amgen Inc. shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's second-quarter profit expectations and hiked its 2015 financial forecast. Amgen, based in Thousand Oaks, California, said Thursday that net income rose to $1.65 billion, or $2.15 per share, ...

Tags: Amgen hikes 2015 forecast after 2Q increase in profit, sales,  Amgen Latest News

JUL 30, 2015 - Wall Street Journal

A Must Read - Share

Amgen Raises 2015 Outlook, Results Beat Expectations

The biotechnology company raised its 2015 guidance after reporting that its second-quarter earnings rose 6.9% on better-than-expected sales growth and lower operating expenses.

Tags: Amgen Raises 2015 Outlook, Results Beat Expectations,  Amgen Latest News

JUL 21, 2015 - Washington Times

A Must Read - Share

Court ruling clears way for Novartis' low-cost biotech drug

WASHINGTON (AP) - A federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug in September, rejecting a bid to further delay the launch of the knock-off biotech medication. Novartis received federal approval in March to sell its cheaper copy of Amgen's ...

Tags: Court ruling clears way for Novartis' low-cost biotech drug,  Amgen Latest News

JUL 21, 2015 - Associated Press

A Must Read - Share

Europe approves Amgen's first-in-class cholesterol drug

WASHINGTON (AP) — Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades.

Tags: Europe approves Amgen's first-in-class cholesterol drug,  Amgen Latest News

JUL 21, 2015 - Seattle Times

A Must Read - Share

Europe approves Amgen’s first-in-class cholesterol drug

WASHINGTON (AP) — Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades. The highly-anticipated decision introduces a new option for patients at risk for heart disease. But questions remain about the drug’s price — estimated by […]

Tags: Europe approves Amgen’s first-in-class cholesterol drug,  Amgen Latest News